Skip to content

Willingness to receive Human Papilloma Virus (HPV) vaccination in patients after surgical treatment for Cervical Intraepithelial Neoplasia

Willingness to receive Human Papilloma Virus (HPV) vaccination in patients after surgical treatment for Cervical Intraepithelial Neoplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON24973
Enrollment
126
Registered
2020-03-24
Start date
2020-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Intraepithelial Neoplasia

Interventions

13-item questionnaire

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: - Cervical intraepithelial neoplasia II or III - Cervical surgery: Large Loop Excision of the Transformation Zone (LLETZ) and conisation

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Age < 18 years - Previous HPV vaccination - Cervical carcinoma - Allergy for vaccination - Poor understanding of the Dutch language

Design outcomes

Primary

MeasureTime frame
Willingness to vaccinate, with or without financial contribution

Secondary

MeasureTime frame
Participants’ common knowledge about HPV infection

Contacts

Public ContactTirza Wouters

Catharina Ziekenhuis Eindhoven

tirza.wouters@student.maastrichtuniversity.nl+31 6 38 54 00 34

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)